Medical Device Global Market Access cover art

Medical Device Global Market Access

Medical Device Global Market Access

By: Pure Global
Listen for free

About this listen

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to technical-file skeletons, we break down the documents you’ll need and the pitfalls reviewers love to flag. • AI-powered insights – Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won’t hear at conferences—or from competitors. What you’ll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a “reg-first” QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regions Whether you’re plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue. ⸻ Brought to you by Pure Global – the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 + countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today.Copyright 2026 Pure Global
Episodes
  • FDA's 2026 AI Device Scrutiny: Lifecycle Governance and Real-World Performance
    Mar 24 2026
    This episode explores the FDA's expected regulatory landscape for AI-enabled medical devices in 2026. We discuss the critical shift from pre-market assessment to a total product lifecycle approach, focusing on the non-negotiable requirements for real-world performance monitoring and Predetermined Change Control Plans (PCCPs). Learn what will separate scalable, approvable medtech platforms from demo-grade algorithms that cannot withstand long-term regulatory scrutiny. - How will the FDA's definition of 'safe and effective' for AI devices change by 2026? - What is a Predetermined Change Control Plan (PCCP) and why will it be mandatory? - Why is real-world performance monitoring becoming more critical than initial pilot data? - What is 'algorithmic drift' and how must manufacturers plan to manage it? - How does clinical workflow integration impact the regulatory viability of an AI device? - What separates a sustainable medtech platform from a simple AI algorithm? - How can you build a lifecycle governance strategy that meets future FDA expectations? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with local expertise and advanced AI tools. From developing a regulatory strategy and compiling your technical dossier to acting as your local representative in over 30 markets, we cover the entire product lifecycle. Our technology-driven approach ensures efficiency and accuracy, helping you navigate complex requirements for market approval and post-market surveillance. To access new markets faster and ensure ongoing compliance, contact Pure Global at info@pureglobal.com, visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Show More Show Less
    3 mins
  • Home-Use Device Recalls & Firmware Updates: Navigating the MedTech Logistical Nightmare
    Mar 15 2026
    This episode delves into the top health technology hazard: the logistical challenges of communicating recalls and firmware updates for home-use medical devices. We explore the fragmented communication chain from manufacturer to patient, the difficulties in executing physical returns and software corrections for non-clinical users, and the regulatory definition of a firmware update as a recall. - Why are home-use device recalls considered the #1 medical tech hazard? - What makes communicating with patients so different from communicating with hospitals? - How does the fragmented supply chain prevent manufacturers from reaching end-users? - Are critical firmware or software updates considered a medical device recall by the FDA? - What were the key communication failures in the massive 2021 CPAP machine recall? - What are the logistical challenges of physically retrieving thousands of devices from patients' homes? - How can companies ensure non-technical users apply critical updates correctly? - What is the Unique Device Identification (UDI) system and how might it solve this problem? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with local expertise and advanced AI. Our services cover the entire product lifecycle, from initial regulatory strategy and technical dossier submission to post-market surveillance and continuous regulatory monitoring. By acting as your local representative in over 30 markets, we ensure your products not only get to market but also maintain compliance in complex, ever-changing regulatory landscapes. Visit us at https://pureglobal.com, contact info@pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Show More Show Less
    3 mins
  • Securing the MedTech Supply Chain: Blockchain vs. 3D-Printed Counterfeits
    Mar 14 2026
    The rise of sophisticated 3D-printed counterfeit medical devices presents a grave threat to patient safety and brand integrity. This episode delves into the escalating battle between counterfeiters and MedTech manufacturers, exploring the cutting-edge technologies being deployed to secure the global supply chain. We examine how solutions like blockchain and invisible marking technologies are becoming essential for verifying product authenticity, ensuring traceability, and complying with increasingly strict international regulations. Key Questions: - How has 3D printing revolutionized the counterfeit medical device industry? - What are the most significant risks counterfeit products pose to patients? - How does blockchain technology create a secure and traceable supply chain? - What are invisible markings, and how do they help verify a product's authenticity? - Why are these expensive technologies becoming a necessary investment for manufacturers? - How do anti-counterfeiting measures align with regulatory requirements like the FDA and EU UDI systems? - What is the impact of counterfeiting on a MedTech company's brand and market access? Navigating the complexities of global supply chain security and regulatory compliance is a significant challenge. Pure Global offers end-to-end consulting for MedTech and IVD companies, leveraging local expertise and advanced AI to streamline global market access. From developing regulatory strategies and managing technical submissions to ensuring post-market surveillance, Pure Global acts as your local representative in over 30 markets. Our technology-driven approach ensures efficiency and accuracy in securing your product's journey to market. Visit https://pureglobal.com/, contact us at info@pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai to accelerate your expansion.
    Show More Show Less
    3 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.